Cargando…

The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study

INTRODUCTION: The search for new ways to optimize the use of medications by patients has led the pharmaceutical community to promote the idea of introducing pictograms into routine practice. The main intention of pictograms is to ease patient adherence and to reduce potential risks or errors associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Merks, Piotr, Świeczkowski, Damian, Balcerzak, Marcin, Drelich, Ewelina, Białoszewska, Katarzyna, Cwalina, Natalia, Krysinski, Jerzy, Jaguszewski, Miłosz, Pouliot, Annie, Vaillancourt, Regis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818874/
https://www.ncbi.nlm.nih.gov/pubmed/29497281
http://dx.doi.org/10.2147/PPA.S150113
_version_ 1783301098483744768
author Merks, Piotr
Świeczkowski, Damian
Balcerzak, Marcin
Drelich, Ewelina
Białoszewska, Katarzyna
Cwalina, Natalia
Krysinski, Jerzy
Jaguszewski, Miłosz
Pouliot, Annie
Vaillancourt, Regis
author_facet Merks, Piotr
Świeczkowski, Damian
Balcerzak, Marcin
Drelich, Ewelina
Białoszewska, Katarzyna
Cwalina, Natalia
Krysinski, Jerzy
Jaguszewski, Miłosz
Pouliot, Annie
Vaillancourt, Regis
author_sort Merks, Piotr
collection PubMed
description INTRODUCTION: The search for new ways to optimize the use of medications by patients has led the pharmaceutical community to promote the idea of introducing pictograms into routine practice. The main intention of pictograms is to ease patient adherence and to reduce potential risks or errors associated with the use of medications. PURPOSE: To evaluate a series of pharmaceutical pictograms for patient comprehension. PATIENTS AND METHODS: The study was conducted in community pharmacies within a European Union country that belongs to the professional research network. Structured interviews were used to evaluate the pictograms for patient comprehension. This consisted of an assessment of the following: the transparency and translucency of the pictograms, health literacy, and pictogram recall. Participants were also given the opportunity to provide feedback on how to improve the pictograms. The primary endpoint was pictogram comprehension. Secondary outcomes included recall of the pictograms and pictogram translucency. RESULTS: The study included 68 patients with whom face-to-face interviews were performed. Low transparency results (≤25%) and extensive patient feedback in initial interviews led to the withdrawal of certain pictograms (n=15) from the evaluation. Among the pictograms included in the final stage of our research, 22 pictograms (62.8%) obtained an acceptable transparency level ≥66%. All pictograms passed the short-term recall test with positive results. CONCLUSION: A majority of the designed and modified pictograms reached satisfactory guess-ability scores. Feedback from patients enabled modification of the pictograms and proved that patients have an important voice in the discussion regarding the design of additional pictograms.
format Online
Article
Text
id pubmed-5818874
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58188742018-03-01 The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study Merks, Piotr Świeczkowski, Damian Balcerzak, Marcin Drelich, Ewelina Białoszewska, Katarzyna Cwalina, Natalia Krysinski, Jerzy Jaguszewski, Miłosz Pouliot, Annie Vaillancourt, Regis Patient Prefer Adherence Original Research INTRODUCTION: The search for new ways to optimize the use of medications by patients has led the pharmaceutical community to promote the idea of introducing pictograms into routine practice. The main intention of pictograms is to ease patient adherence and to reduce potential risks or errors associated with the use of medications. PURPOSE: To evaluate a series of pharmaceutical pictograms for patient comprehension. PATIENTS AND METHODS: The study was conducted in community pharmacies within a European Union country that belongs to the professional research network. Structured interviews were used to evaluate the pictograms for patient comprehension. This consisted of an assessment of the following: the transparency and translucency of the pictograms, health literacy, and pictogram recall. Participants were also given the opportunity to provide feedback on how to improve the pictograms. The primary endpoint was pictogram comprehension. Secondary outcomes included recall of the pictograms and pictogram translucency. RESULTS: The study included 68 patients with whom face-to-face interviews were performed. Low transparency results (≤25%) and extensive patient feedback in initial interviews led to the withdrawal of certain pictograms (n=15) from the evaluation. Among the pictograms included in the final stage of our research, 22 pictograms (62.8%) obtained an acceptable transparency level ≥66%. All pictograms passed the short-term recall test with positive results. CONCLUSION: A majority of the designed and modified pictograms reached satisfactory guess-ability scores. Feedback from patients enabled modification of the pictograms and proved that patients have an important voice in the discussion regarding the design of additional pictograms. Dove Medical Press 2018-02-14 /pmc/articles/PMC5818874/ /pubmed/29497281 http://dx.doi.org/10.2147/PPA.S150113 Text en © 2018 Merks et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Merks, Piotr
Świeczkowski, Damian
Balcerzak, Marcin
Drelich, Ewelina
Białoszewska, Katarzyna
Cwalina, Natalia
Krysinski, Jerzy
Jaguszewski, Miłosz
Pouliot, Annie
Vaillancourt, Regis
The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
title The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
title_full The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
title_fullStr The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
title_full_unstemmed The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
title_short The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
title_sort evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818874/
https://www.ncbi.nlm.nih.gov/pubmed/29497281
http://dx.doi.org/10.2147/PPA.S150113
work_keys_str_mv AT merkspiotr theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT swieczkowskidamian theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT balcerzakmarcin theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT drelichewelina theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT białoszewskakatarzyna theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT cwalinanatalia theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT krysinskijerzy theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT jaguszewskimiłosz theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT pouliotannie theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT vaillancourtregis theevaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT merkspiotr evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT swieczkowskidamian evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT balcerzakmarcin evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT drelichewelina evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT białoszewskakatarzyna evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT cwalinanatalia evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT krysinskijerzy evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT jaguszewskimiłosz evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT pouliotannie evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy
AT vaillancourtregis evaluationofpharmaceuticalpictogramsamongelderlypatientsincommunitypharmacysettingsamulticenterpilotstudy